Displaying 951 - 1000 of 4657 results
Released Company Title Industry Topic
09 Nov 2026
08:00 CET
Cornish Metals plc Q3 ACTIVITIES UPDATE - Additional regulated information required to be disclosed under the laws of a Member State
09 Nov 2026
08:00 CET
DNO ASA Lapse of Offer for Capricorn Energy plc 60101010 Oil: Crude Producers Additional regulated information required to be disclosed under the laws of a Member State
09 Nov 2026
08:00 CET
KUMULUS VAPE Chiffre d'affaires consolidé du 3e trimestre 2026 : 13,2 MEUR 40401030 Specialty Retailers Sales, Income
09 Nov 2026
08:00 CET
5TH PLANET GAMES 47-2026 5th Planet Games A/S Proposes New Underwritten Rights Issue to Support Expanded Games Publishing and Co-Financing Strategy 40203045 Toys Inside information
09 Nov 2026
08:00 CET
Questerre Energy Corporation Questerre to host webcast for third quarter 2026 results on November 13, 2026 at 1530 CET 60101010 Oil: Crude Producers Non-regulatory press releases
09 Nov 2026
08:00 CET
Alpine Energy, LLC Interim Report for Q3 2026 - Half yearly financial reports and audit reports/limited reviews
09 Nov 2026
08:00 CET
Wilh. Wilhelmsen Holding ASA Wilh. Wilhelmsen Holding ASA: Initiating offer to buy back own shares 50206060 Transportation Services Inside information
09 Nov 2026
07:52 CET
AKVA GROUP AKVA group ASA: 90% Minimum Acceptance condition satisfied for the recommended voluntary offer 50204000 Machinery: Industrial Additional regulated information required to be disclosed under the laws of a Member State
09 Nov 2026
07:30 CET
AKOBO MINERALS AB (PUB) Akobo Minerals - Operational Update for October 2026 55103025 Gold Mining Non-regulatory press releases
09 Nov 2026
07:30 CET
GENFIT GENFIT présente les données issues des études cliniques de nangibotide soutenant la poursuite de son développement dans l’ACLF. Résultats de phase 2 attendus en 2027 20103010 Biotechnology Other subject
09 Nov 2026
07:30 CET
GENFIT GENFIT Highlights Data from Clinical Studies of Nangibotide, Supporting Its Advancement into ACLF with Phase 2 Data Expected in 2027 20103010 Biotechnology Other subject
09 Nov 2026
07:30 CET
ARTMARKET.COM(EX ARTPRICE.COM) Artmarket.com (Artprice) : CA 3T2026 en hausse, déploiement mondial début 12/ 2026 d'Artprice Visual Search(R), le " saut quantique " de 30 ans de stratégie IA-First 40301030 Publishing Sales, Income
09 Nov 2026
07:30 CET
ERAMET Eramet outlines its short- and medium-term operational and strategic roadmap 55102050 Nonferrous Metals Corporate life
09 Nov 2026
07:30 CET
ERAMET Eramet précise sa feuille de route opérationnelle et stratégique à court et moyen terme 55102050 Nonferrous Metals Corporate life
09 Nov 2026
07:17 CET
DOF Group ASA DOF Group ASA - Contract extension for Skandi Mariner 50101015 Engineering and Contracting Services Non-regulatory press releases
09 Nov 2026
07:05 CET
PELAGIC CREDIT PLC Pelagic Credit Plc: Key information relating to the cash dividend 50206030 Marine Transportation Additional regulated information required to be disclosed under the laws of a Member State
09 Nov 2026
07:00 CET
APPEAR ASA Appear ASA Invitation to Capital Markets Day 7 December 2026 15101010 Telecommunications Equipment Non-regulatory press releases
09 Nov 2026
07:00 CET
APPEAR ASA Appear ASA - Invitation to Capital Markets Day 7 December 2026 15101010 Telecommunications Equipment Non-regulatory press releases
09 Nov 2026
07:00 CET
VALNEVA SE Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2 20103015 Pharmaceuticals Products and services
09 Nov 2026
07:00 CET
Telenor ASA Status update share buyback program 15102015 Telecommunications Services Acquisition or disposal of the issuer’s own shares
09 Nov 2026
07:00 CET
CASINO GUICHARD Plesio : Postponement of the Q3 2026 activity release 45201010 Food Retailers and Wholesalers Other subject
09 Nov 2026
07:00 CET
VALNEVA SE Valneva annonce des résultats positifs de phase 2 pour son candidat vaccin tétravalent contre la shigellose S4V2 20103015 Pharmaceuticals Products and services
09 Nov 2026
07:00 CET
ARGENX SE argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities 20103010 Biotechnology Other subject
09 Nov 2026
07:00 CET
CASINO GUICHARD Plesio : Report de la publication de l’activité du T3 2026 45201010 Food Retailers and Wholesalers Other subject
09 Nov 2026
07:00 CET
CREDIT AGRICOLE CREDIT AGRICOLE SA: CRÉDIT AGRICOLE PROPONE A BANCO BPM DI CREARE INSIEME UN NUOVO CAMPIONE BANCARIO ITALIANO 30101010 Banks Other subject
09 Nov 2026
07:00 CET
CREDIT AGRICOLE CREDIT AGRICOLE SA : CRÉDIT AGRICOLE PROPOSE À BANCO BPM DE CRÉER ENSEMBLE UN NOUVEAU CHAMPION BANCAIRE ITALIEN 30101010 Banks Other subject
09 Nov 2026
07:00 CET
CREDIT AGRICOLE CREDIT AGRICOLE SA: CRÉDIT AGRICOLE PROPOSES TO BANCO BPM TO CREATE TOGETHER A NEW LEADING ITALIAN BANK 30101010 Banks Other subject
09 Nov 2026
07:00 CET
BIOTALYS NV Biotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA® NG 55201015 Fertilizers -
09 Nov 2026
07:00 CET
Telenor ASA Status tilbakekjøp av egne aksjer 15102015 Telecommunications Services Utsteders meldeplikt ved handel i egne aksjer
09 Nov 2026
07:00 CET
BIOGEN ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE Using Novel Treatment Response Measure - -
09 Nov 2026
07:00 CET
CTP NV CTP accelerates Asian expansion with proposed acquisition of SLP portfolio and operating platform in Vietnam for ~US$500 million 35101010 Real Estate Holding and Development Alliances and agreements
09 Nov 2026
07:00 CET
BIOMERIEUX bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus 20102010 Medical Equipment Other subject
09 Nov 2026
07:00 CET
LYTIX BIOPHARMA ASA Lytix Biopharma to Present NeoLIPA Phase II Results in Late-Breaking Oral Presentation at ESMO IO 2026 20103010 Biotechnology Non-regulatory press releases
09 Nov 2026
07:00 CET
BIOMERIEUX bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus 20102010 Medical Equipment Other subject
09 Nov 2026
07:00 CET
BIOPHYTIS BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA 20103010 Biotechnology Legal
09 Nov 2026
07:00 CET
BIOPHYTIS Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine 20103010 Biotechnology Legal
09 Nov 2026
07:00 CET
LYTIX BIOPHARMA ASA Lytix Biopharma presenterer late-breaking fase II-resultater fra NeoLIPA på ESMO IO 2026 20103010 Biotechnology Ikke-informasjonspliktige pressemeldinger
09 Nov 2026
07:00 CET
PELAGIC CREDIT PLC Pelagic Credit Plc - Third quarter results 2026 50206030 Marine Transportation Half yearly financial reports and audit reports/limited reviews
09 Nov 2026
06:59 CET
HUNTER GROUP Hunter Group ASA - Business Update on reduced charter hire from one of the counterparties. 60101030 Oil Equipment and Services Inside information
09 Nov 2026
06:47 CET
JENSEN-GROUP Inkoop eigen aandelen - wekelijkse update 50204000 Machinery: Industrial Other subject
09 Nov 2026
06:47 CET
JENSEN-GROUP Share buyback – weekly update 50204000 Machinery: Industrial Other subject
09 Nov 2026
02:07 CET
ZENITH ENERGY Republic of Tunisia Fails to honour ICSID Arbitration Payment Obligations 60101010 Oil: Crude Producers Inside information
08 Nov 2026
19:04 CET
HYLORIS Alenura® Delivers Positive Phase 2 Results in Interstitial Cystitis/Bladder Pain Syndrome Trial 20103010 Biotechnology Corporate life
08 Nov 2026
18:00 CET
Hegra Sparebank Hegra Sparebank - utvidelse og tilbakekjøp av obligasjonslån - Annen informasjonspliktig regulatorisk informasjon
08 Nov 2026
18:00 CET
Hegra Sparebank HESB28 PRO - Nøkkelinformasjon ved innfrielse av deler av senior obligasjonslån - Annen informasjonspliktig regulatorisk informasjon
07 Nov 2026
17:49 CET
HYLORIS Hyloris Signs Exclusive Distribution Agreement with AFT Pharmaceuticals for Phosphate Oral Liquid in Five International Markets 20103010 Biotechnology Corporate life
07 Nov 2026
17:47 CET
HYLORIS Disclosure of a received transparency notification in accordance with article 14 of the act of 2 May 2007 on disclosure of large shareholdings 20103010 Biotechnology Corporate life
07 Nov 2026
17:47 CET
HYLORIS Hyloris Announces the final Conversion Price of its EUR 1 Million Convertible Bonds 20103010 Biotechnology Corporate life
07 Nov 2026
16:01 CET
ARGENX SE argenx Presents Phase 3 ALKIVIA Data at ACR Convergence 2026 Showing Rapid and Sustained Improvement with Efgartigimod in Autoimmune Myositis 20103010 Biotechnology Other subject
06 Nov 2026
21:53 CET
OTELLO CORPORATION Otello Corporation share buyback program status 10101020 Consumer Digital Services Acquisition or disposal of the issuer’s own shares